Swiss National Bank
ARRY

Swiss National Bank’s Array Biopharma Inc ARRY Stock Holding History

Swiss National Bank’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-406,100
Closed -$18.8M – 2539
2019
Q2 		$18.8M Buy
406,100
+37,200
+10% +$1.04M 0.02% 597
2019
Q1 		$8.99M Buy
368,900
+11,800
+3% +$246K 0.01% 774
2018
Q4 		$5.09M Buy
357,100
+8,100
+2% +$123K 0.01% 972
2018
Q3 		$5.3M Buy
349,000
+5,600
+2% +$85.8K 0.01% 1079
2018
Q2 		$5.76M Buy
343,400
+17,800
+5% +$283K 0.01% 999
2018
Q1 		$5.31M Buy
325,600
+16,900
+5% +$271K 0.01% 1010
2017
Q4 		$3.95M Buy
308,700
+6,300
+2% +$71.7K ﹤0.01% 1209
2017
Q3 		$3.72M Buy
302,400
+35,000
+13% +$325K ﹤0.01% 1205
2017
Q2 		$2.24M Buy
267,400
+17,400
+7% +$142K ﹤0.01% 1517
2017
Q1 		$2.23M Buy
250,000
+8,200
+3% +$87.2K ﹤0.01% 1493
2016
Q4 		$2.13M Sell
241,800
-13,900
-5% -$102K ﹤0.01% 1508
2016
Q3 		$1.73M Buy
255,700
+44,000
+21% +$170K ﹤0.01% 1608
2016
Q2 		$754K Sell
211,700
-23,100
-10% -$75.3K ﹤0.01% 2125
2016
Q1 		$669K Buy
234,800
+43,600
+23% +$131K ﹤0.01% 2150
2015
Q4 		$807K Hold
191,200
– – ﹤0.01% 1967
2015
Q3 		$872K Buy
191,200
+24,900
+15% +$148K ﹤0.01% 1849
2015
Q2 		$1.2M Buy
166,300
+22,300
+15% +$165K ﹤0.01% 1684
2015
Q1 		$1.06M Hold
144,000
– – ﹤0.01% 1734
2014
Q4 		$681K Buy
144,000
+6,300
+5% +$24.9K ﹤0.01% 1973
2014
Q3 		$492K Hold
137,700
– – ﹤0.01% 2113
2014
Q2 		$628K Hold
137,700
– – ﹤0.01% 2031
2014
Q1 		$647K Buy
137,700
+28,300
+26% +$142K ﹤0.01% 1985
2013
Q4 		$548K Hold
109,400
– – ﹤0.01% 1927
2013
Q3 		$680K Sell
109,400
-4,400
-4% -$26.1K ﹤0.01% 1726
2013
Q2 		$517K Buy
+113,800
New +$612K ﹤0.01% 1893

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Swiss National Bank's ARRY Position: Q3 2019 in Review

Swiss National Bank sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 406,100 shares — an estimated $18.8M sold.

Swiss National Bank first reported a position in ARRY in Q2 2013 and held it in 25 quarters. The position peaked at $18.8M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Swiss National Bank reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Swiss National Bank sold 406,100 Array Biopharma Inc shares in Q3 2019, an estimated $18.8M.
  • Swiss National Bank first reported a position in Array Biopharma Inc in Q2 2013 and held it in 25 quarters.
  • Swiss National Bank's Array Biopharma Inc position peaked at $18.8M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Swiss National Bank's 13F filing for Q3 2019, filed 12 Nov 2019.